NASDAQ:OCGN
Ocugen Stock News
$1.59
-0.0800 (-4.79%)
At Close: May 10, 2024
3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street
05:21am, Wednesday, 02'nd Nov 2022
Select analysts and pundits foresee game-changing upside from this fast-paced trio.
Warning! Don't Even Consider Buying These 7 Dead-Money Stocks
07:42pm, Tuesday, 01'st Nov 2022
Financial markets have been in turmoil for the better part of the past six months. The stock market has plunged to new lows as the Federal Reserve tightens the screws with rampant interest rate hikes.
Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences
08:00am, Thursday, 06'th Oct 2022
MALVERN, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel g
Ocugen, Inc. to Present at Chardan's 6th Annual Genetic Medicines Conference
07:30am, Thursday, 29'th Sep 2022
MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel
Why Is Ocugen (OCGN) Stock Up Today?
10:15am, Wednesday, 28'th Sep 2022
Ocugen (NASDAQ: OCGN ) stock was up nearly 15% today in premarket trading after the biotechnology company announced that Washington University has signed a licensing agreement with the company for its
7 Growth Stocks to Sell Now
04:05pm, Thursday, 08'th Sep 2022
As Washington's fiscal and monetary stimulus has wound down, meme stocks and cryptocurrencies are tumbling tremendously. Consequently, any names connected to either phenomenon are good growth stocks t
Why Ocugen Stock Topped the Market Today
06:28pm, Thursday, 01'st Sep 2022
The company appointed not one, but two new top managers to crucial posts.
Why Ocugen Stock Is Racing Higher Today
03:36pm, Wednesday, 24'th Aug 2022
An analyst thinks the biotech could have an important new gene therapy on its hands.
Are Ocugen or Amarin Good Penny Stocks to Buy?
01:12am, Wednesday, 24'th Aug 2022
This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing.
Here's How This Beaten-Down Stock Could 10X by 2024
09:45am, Saturday, 13'th Aug 2022
A moonshot won't be necessary, but it'll require a bit of a pivot.
Ocugen CEO to Present at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
07:30am, Friday, 12'th Aug 2022
MALVERN, Pa., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel g
Ocugen, Inc. (OCGN) CEO Shankar Musunuri on Q2 2022 Results - Earnings Call Transcript
01:09pm, Friday, 05'th Aug 2022
Ocugen, Inc. (NASDAQ:OCGN ) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executi
Ocugen Q2 Preview: Rebound Quarter Inbound?
06:48pm, Wednesday, 03'rd Aug 2022
Ocugen shares have struggled over the last year, declining more than 60% in value and vastly underperforming the S&P 500.
MALVERN, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel c
Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today
12:30pm, Thursday, 14'th Jul 2022
Healthcare has become a bona fide stock picker's market this year.
